Weight loss injections, particularly the newer generation of GLP-1 receptor agonists such as semaglutide (Wegovy) and tirzepatide (Mounjaro), require refrigeration to maintain their stability and therapeutic efficacy
Omzo's published disclosures note it does not sell, dispense, or ship branded medications under its standard model - availability of branded options should be confirmed directly with Omzo prior to enrollment
We take ownership of this issue and were working 24/7 to correct it, says Langa, but its going to take some time to meet the demand. He expects this to happen by early 2022, if not sooner. Temporary shortage issues aside, the response to Wegovys launch led investment banking company Jefferies to report that the drug has the potential to at least double or triple the obesity market
An Eli Lilly funded scientist is set to present rodent data at the American Diabetes Association meeting on a quintuple agonist, a five pathway compound that has already edged out retatrutide in rat weight loss
Glenmark Pharmaceuticals Ltd